Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06920628 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor 5 versions Re-verified since Sep 19, 2025, no change to tracked fieldsv44-v48
  2. Minor Eligibility criteria expanded, about 15 wordsv43
  3. Minor 2 versions Re-verified since Sep 4, 2025, no change to tracked fieldsv41-v42
  4. Minor Start date changed from estimate of Jun 26, 2025 to Jun 18, 2025v40
  5. Minor Start date: Jun 24, 2025 to Jun 26, 2025v39
Show 37 earlier versionsHide 37 earlier versions
  1. Minor Start date: Jun 23, 2025 to Jun 24, 2025v38
  2. Minor Start date: Jun 20, 2025 to Jun 23, 2025v37
  3. Minor Start date: Jun 19, 2025 to Jun 20, 2025v36
  4. Minor Start date: Jun 18, 2025 to Jun 19, 2025v35
  5. Minor Start date: Jun 17, 2025 to Jun 18, 2025v34
  6. Minor Start date: Jun 16, 2025 to Jun 17, 2025v33
  7. Minor Start date: Jun 15, 2025 to Jun 16, 2025v32
  8. Minor Start date: Jun 12, 2025 to Jun 15, 2025v31
  9. Minor Start date: Jun 11, 2025 to Jun 12, 2025v30
  10. Minor Start date: Jun 10, 2025 to Jun 11, 2025v29
  11. Minor Start date: Jun 9, 2025 to Jun 10, 2025v28
  12. Minor Start date: Jun 8, 2025 to Jun 9, 2025v27
  13. Minor Start date: Jun 5, 2025 to Jun 8, 2025v26
  14. Minor Start date: Jun 3, 2025 to Jun 5, 2025v25
  15. Minor Start date: Jun 2, 2025 to Jun 3, 2025v24
  16. Minor Start date: May 29, 2025 to Jun 2, 2025v23
  17. Minor Start date: May 28, 2025 to May 29, 2025v22
  18. Minor Start date: May 27, 2025 to May 28, 2025v21
  19. Minor Start date: May 26, 2025 to May 27, 2025v20
  20. Minor Start date: May 25, 2025 to May 26, 2025v19
  21. Minor Start date: May 22, 2025 to May 25, 2025v18
  22. Minor Start date: May 21, 2025 to May 22, 2025v17
  23. Minor Start date: May 20, 2025 to May 21, 2025v16
  24. Minor Start date: May 19, 2025 to May 20, 2025v15
  25. Minor Start date: May 16, 2025 to May 19, 2025v14
  26. Minor Start date: May 15, 2025 to May 16, 2025v13
  27. Minor Start date: May 14, 2025 to May 15, 2025v12
  28. Minor Start date: May 13, 2025 to May 14, 2025v11
  29. Minor Start date: May 12, 2025 to May 13, 2025v10
  30. Minor Start date: May 11, 2025 to May 12, 2025v9
  31. Minor Start date: May 8, 2025 to May 11, 2025v8
  32. Minor Start date: May 7, 2025 to May 8, 2025v7
  33. Minor Start date: May 6, 2025 to May 7, 2025v6
  34. Minor Start date: May 5, 2025 to May 6, 2025v5
  35. Minor Start date: May 4, 2025 to May 5, 2025v4
  36. Minor Start date: May 1, 2025 to May 4, 2025v3
  37. Minor Start date: Apr 30, 2025 to May 1, 2025v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from COVID-19 have long-term symptoms that affect the brain. These include headaches; loss of taste and smell; sleep problems; thinking problems; depression; and anxiety. Researchers want to know if a tracer (a substance that is injected into a person s body before an imaging scan) can help identify inflammation in people with these brain disorders. Objective: To see if a radioactive tracer (\[11C\]PS13) can highlight brain inflammation in those who had COVID-19 but still have symptoms that affect the brain. Eligibility: Adults aged 18 to 70 years with post COVID-19 brain disorders who are enrolled in protocol 000089 or 000711. Healthy volunteers are also needed. Design: Participants will have up to 5 clinic visits. Participants will be screened. They will have blood tests and a test of their heart function. They will have imaging scans: Magnetic resonance imaging (MRI): They will lie on a table that slides into a metal tube. Pictures will be taken of the brain. Positron emission tomography (PET): A needle attached to a thin tube will be inserted into a vein in the arm. The tracer will be injected through the tube. Another needle attached to a thin tube will be inserted into the wrist or inside of the elbow of the other arm to draw blood. They will lie still on a bed while a machine captures images of their brain. The scan will last about 2 hours. Study involvement is 11 to 14 weeks....
Trial Details
NCT Number NCT06920628
Lead Sponsor National Institute of Mental Health (NIMH)
Conditions
(from sponsor)
Long COVID, Post Acute Sequelae of COVID-19
Related terms Inflammation, Post-Acute COVID-19 Syndrome
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov